Exploring New Anticancer Agents and Mechanisms in Urologic Cancers

392
Total downloads
3,330
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Accepted on 24 Nov 2025

Darolutamide-Based Triple Therapy Combined with PSMA imaging Guided Focal Treatment in Patients with Prostate Cancer: A Multicenter Retrospective Study

Dewen Zhong
Ruochen Zhang
Jinling Wu
Zhixun Guo
Yu Zhang
Qinfei Zhou
Zijun Zou
Deng Lin
Zhonglei Lu
3 more
Yongbao Wei

BRIEF RESEARCH REPORT

Published on 05 Nov 2025

Serial TIL infusions and PD-1 blockade drive long-term clonal persistence in prostate cancer

Lucas C. M. Arruda
Julia Karbach
Dragan Kiselicki
Kathrin Brand
Claudia Wahle
Evgueni Sinelnikov
Dirk Gustavus
Hans Hoffmeister
Akin Atmaca
Elke Jäger

doi 10.3389/fonc.2025.1693912

1,133 views

REVIEW

Published on 04 Jul 2025

MicroRNA-145 in urologic tumors: biological roles, regulatory networks, and clinical translation

Lifeng Gan
Wei Li
Qi Chen
Le Cheng
Fangtao Zhang
Haidong Zhong
Yiran Lu
Liying Zheng
Biao Qian

doi 10.3389/fphar.2025.1609646

1,151 views

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Pharmacology of Anti-Cancer Drugs

Participating Journals

Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

3,330Topic views
2,254Article views
392Article downloads